A recent report from the Centers for Disease Control and Prevention (CDC) has signaled an alarm: kratom-related poisonings in the United States have surged, with a staggering 1,200% increase over the last decade. However, medical experts warn that these statistics may be misleading, as they fail to distinguish between the natural plant and dangerous new synthetic derivatives.
This distinction is at the heart of a growing conflict between regulators seeking to curb drug abuse and patients who rely on the natural plant for pain management and addiction recovery.
The 7-OH Factor: A New Synthetic Threat
The primary driver behind the recent spike in poisonings appears to be the emergence of 7-hydroxymitragynine (7-OH). While 7-OH exists in trace amounts within the natural Mitragyna speciosa plant, it is increasingly being isolated and marketed as a concentrated, “superior” alkaloid.
Experts note several critical issues with the rise of 7-OH:
– Marketing Confusion: 7-OH is often sold in energy drinks and other products under the guise of “kratom,” leading consumers and poison control centers to conflate the two.
– Opioid-like Risks: Unlike the natural plant, concentrated 7-OH carries significant risks, including severe addiction, intense withdrawal symptoms, and respiratory depression —the primary cause of fatal opioid overdoses.
– Safety Profiles: While 7-OH acts heavily on opioid receptors, natural kratom interacts with a broader range of receptors (including adrenergic and serotonin receptors), which may explain why it lacks the extreme euphoria and lethal respiratory risks of classic opioids.
A Lifeline for Chronic Pain and Recovery
Despite the dangers posed by synthetic derivatives, many users view natural kratom as a vital tool for managing life-altering conditions. For a significant portion of the user base, kratom serves two primary purposes:
- Chronic Pain Management: Many users suffer from debilitating conditions like osteoarthritis, using the plant to manage pain without the high risks associated with prescription opioids.
- Addiction Recovery: Roughly 40% of kratom users report using the substance to assist in recovering from addictions to opioids, alcohol, or stimulants.
For many, the transition to kratom is a matter of necessity. Patients who have had their opioid prescriptions revoked or who cannot afford traditional addiction treatments often turn to kratom to avoid the “unbearable” physical agony of withdrawal.
The Danger of “Blanket Bans”
The current regulatory trend leans toward total prohibition, but experts argue that treating natural kratom and synthetic 7-OH as the same substance is a scientific error.
“These products may offer meaningful benefits to some individuals, and those benefits could be lost if access is restricted too broadly,” warns Austin Zamarripa, a psychiatry professor at Johns Hopkins University.
The push for blanket bans raises several concerns:
– Loss of Therapeutic Access: Prohibiting the natural plant could strip away a management tool for those in recovery or living with chronic pain.
– Regulatory Misalignment: Experts suggest that instead of a total ban, regulators should focus on strictly controlling concentrated 7-OH products, which pose the most immediate threat to public safety.
– Unaddressed Risks: While natural kratom is considered relatively safe, experts still note risks such as potential heavy metal contamination and the possibility of users “cycling” between kratom and potent opioids like fentanyl.
Conclusion
The surge in kratom-related poisonings highlights a critical need for nuanced regulation. While the rise of synthetic 7-OH presents a genuine public health crisis, a blanket ban on the natural plant risks harming a vulnerable population that relies on it for pain relief and addiction recovery.
